Nyxthracis (previously Obiltoxaximab SFL) Европска Унија - Хрватски - EMA (European Medicines Agency)

nyxthracis (previously obiltoxaximab sfl)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - imuni serumi i homologna, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Celixib 100 mg tvrde kapsule Хрватска - Хрватски - HALMED (Agencija za lijekove i medicinske proizvode)

celixib 100 mg tvrde kapsule

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - celekoksib - kapsula, tvrda - 100 mg - urbroj: jedna tvrda kapsula sadrži 100 mg celekoksiba

Celixib 200 mg tvrde kapsule Хрватска - Хрватски - HALMED (Agencija za lijekove i medicinske proizvode)

celixib 200 mg tvrde kapsule

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - celekoksib - kapsula, tvrda - 200 mg - urbroj: jedna tvrda kapsula sadrži 200 mg celekoksiba